MMP9 and small cell lung carcinoma: The results showed that upregulating the expression level of MMP9 (H69-MMP9, H446-MMP9) in chemotherapy-resistant small cell lung cancer cells significantly reduced the IC50 value of SCLC cells to chemotherapy drugs (Figures 7C,D), and the subsequent chemotherapy resistance of cells decreased.